PK and PD Study of NPI-001 and Cysteamine Bitartrate
Clinical trial NCT05994534 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05994534
- Sponsor
- Nacuity Pharmaceuticals, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-29
- Primary completion
- 2026-08-01
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.